{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T20:44:43Z","timestamp":1762375483117,"version":"3.32.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"vor","delay-in-days":4842,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["intpsychogeriatrics.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Psychogeriatrics"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1017\/s1041610211000421","type":"journal-article","created":{"date-parts":[[2011,3,24]],"date-time":"2011-03-24T10:42:32Z","timestamp":1300963352000},"page":"1260-1269","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["A 12-month follow-up study of \u201cRedUSe\u201d: a trial aimed at reducing antipsychotic and benzodiazepine use in nursing homes"],"prefix":"10.1016","volume":"23","author":[{"given":"Juanita","family":"Westbury","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisette","family":"Tichelaar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Gee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shane","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1017\/S1041610211000421_bb0010","unstructured":"Aged Care Standards and Accreditation Agency (2011). Accreditation Overview. Available at www.accreditation.org.au\/accrediation; last accessed 20 January 2011."},{"year":"2007","author":"American Psychiatric Association","key":"10.1017\/S1041610211000421_bb0015"},{"key":"10.1017\/S1041610211000421_bb0020","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1056\/NEJM199207163270306","article-title":"A randomised trial of a program to reduce the use of psychoactive drugs in nursing homes","volume":"327","author":"Avorn","year":"1992","journal-title":"New England Journal of Medicine"},{"key":"10.1017\/S1041610211000421_bb0025","first-page":"CD003476","article-title":"Atypical antipsychotics for aggression and psychosis in Alzheimer's disease","volume":"1","author":"Ballard","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1017\/S1041610211000421_bb0030","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S1474-4422(08)70295-3","article-title":"The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial","volume":"8","author":"Ballard","year":"2009","journal-title":"Lancet Neurology"},{"year":"2009","series-title":"The Use of Antipsychotic Medication for People with Dementia: Time for Action","author":"Banerjee","key":"10.1017\/S1041610211000421_bb0035"},{"key":"10.1017\/S1041610211000421_bb0040","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2165\/00002512-200623040-00001","article-title":"Use of sleep-promoting medications in nursing home residents","volume":"23","author":"Conn","year":"2006","journal-title":"Drugs and Aging"},{"key":"10.1017\/S1041610211000421_bb0045","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1136\/bmj.38782.575868.7C","article-title":"Effect of enhanced psychosocial care on antipsychotic use in nursing home residents with severe dementia: cluster randomised trial","volume":"332","author":"Fossey","year":"2006","journal-title":"BMJ"},{"key":"10.1017\/S1041610211000421_bb0050","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1017\/S1041610209991505","article-title":"Management of behavioral problems in Alzheimer's disease","volume":"22","author":"Gauthier","year":"2010","journal-title":"International Psychogeriatrics"},{"key":"10.1017\/S1041610211000421_bb0055","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1136\/bmj.38623.768588.47","article-title":"Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits","volume":"331","author":"Glass","year":"2005","journal-title":"BMJ"},{"key":"10.1017\/S1041610211000421_bb0060","unstructured":"International Psychogeriatric Association (2004). Primary Care Physicians Guide to BPSD. Available at www.ipa-online.net; last accessed 14 March 2009."},{"key":"10.1017\/S1041610211000421_bb0065","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/sj.npp.1301492","article-title":"ACNP White Paper: update on use of antipsychotic drugs in elderly persons with dementia","volume":"33","author":"Jeste","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1017\/S1041610211000421_bb0070","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.amjopharm.2008.10.002","article-title":"Antipsychotic drug use among elderly nursing home residents in the United States","volume":"6","author":"Kamble","year":"2008","journal-title":"American Journal of Geriatric Pharmacotherapy"},{"key":"10.1017\/S1041610211000421_bb0075","unstructured":"National Prescribing Service (2008). Medication Management in Residential Aged Care: Drugs for Dementia in Alzheimer's Disease. Canberra: National Prescribing Service. Available at: http:\/\/agedcare.nps.org.au\/clinical_info\/feature_topics\/topics\/feature_topic; last accessed 10 October 2010."},{"key":"10.1017\/S1041610211000421_bb0080","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/JGP.0b013e31817c6abe","article-title":"Psychotropic prescribing in long-term care facilities: Impact of Medication Reviews and Educational Interventions","volume":"16","author":"Nishtala","year":"2008","journal-title":"American Journal of Geriatric Psychiatry"},{"key":"10.1017\/S1041610211000421_bb0085","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.2105\/AJPH.77.11.1448","article-title":"Reducing antipsychotic drug prescribing for nursing home patients: a controlled trial of the effect of an educational visit","volume":"77","author":"Ray","year":"1987","journal-title":"American Journal of Public Health"},{"key":"10.1017\/S1041610211000421_bb0090","unstructured":"Royal Australian College of General Practitioners (2000). Guidelines for the Rational Use of Benzodiazepines. Available at www.racgp.org.au\/publications. Last accessed 6 March 2009."},{"key":"10.1017\/S1041610211000421_bb0095","doi-asserted-by":"crossref","first-page":"433","DOI":"10.2165\/00044011-200020060-00006","article-title":"Quality of drug use in Swedish nursing homes: a follow-up study","volume":"20","author":"Schmidt","year":"2000","journal-title":"Clinical Drug Investigations"},{"key":"10.1017\/S1041610211000421_bb0100","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1532-5415.1998.tb01017.x","article-title":"The impact of regular multidisciplinary team interventions on psychotropic prescribing in Swedish Nursing homes","volume":"46","author":"Schmidt","year":"1998","journal-title":"Journal of the American Geriatric Society"},{"key":"10.1017\/S1041610211000421_bb0105","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/01.JGP.0000200589.01396.6d","article-title":"Efficacy and adverse effects of atypical antipsychotics for dementia: Meta-analysis of randomised, placebo-controlled trials","volume":"14","author":"Schneider","year":"2006","journal-title":"American Journal of Geriatric Psychiatry"},{"key":"10.1017\/S1041610211000421_bb0110","first-page":"1","article-title":"Current use of psychotropic medication in nursing homes","volume":"17","author":"Snowdon","year":"2005","journal-title":"International Psychogeriatrics"},{"year":"2010","series-title":"Maudsley Prescribing Guidelines","author":"South London and Maudsley NHS Foundation Trust Oxleas NHS Foundation Trust","key":"10.1017\/S1041610211000421_bb0115"},{"key":"10.1017\/S1041610211000421_bb0120","first-page":"18","article-title":"Use of psychotropic medicines in residential care facilities for older people in Hawke's Bay, New Zealand","volume":"121","author":"Tucker","year":"2008","journal-title":"New Zealand Journal of Medicine"},{"key":"10.1017\/S1041610211000421_bb0125","first-page":"438","article-title":"Effect of regulatory warnings on antipsychotic prescription rates among elderly patients with dementia: a population-based time-series analysis","volume":"179","author":"Valiyeva","year":"2008","journal-title":"Canadian Medical Journal"},{"key":"10.1017\/S1041610211000421_bb0130","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1017\/S1041610209991128","article-title":"An effective approach to decrease antipsychotic and benzodiazepine use in nursing homes","volume":"22","author":"Westbury","year":"2010","journal-title":"International Psychogeriatrics"},{"key":"10.1017\/S1041610211000421_bb0135","doi-asserted-by":"crossref","first-page":"663","DOI":"10.4088\/JCP.v64n0607","article-title":"Chlorpromazine equivalent doses for the newer atypical antipsychotics","volume":"64","author":"Woods","year":"2003","journal-title":"Journal of Clinical Psychiatry"},{"year":"2006","series-title":"Guidelines for ATC Classification and DDD Assignment","author":"World Health Organization","key":"10.1017\/S1041610211000421_bb0140"},{"key":"10.1017\/S1041610211000421_bb0145","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.amjopharm.2010.05.004","article-title":"Interventions to improve suboptimal prescribing in nursing homes: a narrative review","volume":"8","author":"Zachary","year":"2010","journal-title":"American Journal of Geriatric Pharmacotherapy"}],"container-title":["International Psychogeriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1041610224021951?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1041610224021951?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1041610211000421","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T16:23:41Z","timestamp":1735835021000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1041610224021951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S1041610224021951"],"URL":"https:\/\/doi.org\/10.1017\/s1041610211000421","relation":{},"ISSN":["1041-6102"],"issn-type":[{"type":"print","value":"1041-6102"}],"subject":[],"published":{"date-parts":[[2011,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A 12-month follow-up study of \u201cRedUSe\u201d: a trial aimed at reducing antipsychotic and benzodiazepine use in nursing homes","name":"articletitle","label":"Article Title"},{"value":"International Psychogeriatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1017\/S1041610211000421","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Copyright \u00a9 International Psychogeriatric Association 2011. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}